Back to News
Market Impact: 0.18
UBS Initiates Coverage of Core Scientific, Inc. - Equity Right at Buy
Source: Nasdaq
Analyst InsightsCompany Fundamentals
UBS initiated coverage of Core Scientific, Inc. Equity Right (OTCPK:CORZR) with a Buy rating on September 23, 2026. The article characterizes the initiation as part of a series of recent analyst actions, but provides no price target, earnings estimates, or other financial details to quantify the investment case.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
CORZ0.45
UBS0.00
More News
- CoreWeave seeks truce with Texas Governor-elect Hinojosa
- These funds tout hefty income tied to the tech trade – if you’re willing to deal with the complexity
- Street Calls of The Week
- Meta’s $25 Billion Bond Sale Highlights Shifting Landscape for Tech Debt
- Binance CFO exits days after catastrophic $6 billion crypto hack
- Coffee giant Dutch Bros made all of its executives, including the CEO, do a two-week bootcamp where they learned how to pour drinks and run stores